KCNMA1 and Ataxia: Systemic paxilline administration in our in vivo experiments (8 mg/kg BW, twice per day) provoked ataxia due to the blockade of BK channels in the cerebellum [31] indicating that paxilline crosses the blood-brain barrier and reached effectiv concentrations in the brain.